Nanjing Gaoke Co (SHSE:600064) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600064 Nanjing Gaoke Co Ltd SHSE:600064
58 GF Score
Price ¥7.45
GF Value ¥7.83
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Nanjing Gaoke Co FFO per Share?

FFO per Share only applies to REITs.

SHSE:600064
58GF Score
Nanjing Gaoke Co Ltd SHSE:600064
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanjing Gaoke Co (SHSE:600064) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Gaoke Co stock appears to be undervalued. The current stock price of ¥7.45 is trading 4.9% below its estimated GF Value™ of ¥7.83. GuruFocus considers Nanjing Gaoke Co to be Fairly Valued.

Key valuation signals for SHSE:600064:

  • FFO per Share:
  • GF Value™: ¥7.83 vs. price of ¥7.45 (4.9% below fair value)
  • GF Score™: 58/100 with 9 warning signs

No single metric tells the full story. See the SHSE:600064 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nanjing Gaoke Co Business Description

Address 129 Newport Avenue, Nanjing Economic and Technological Development Zone, Nanjing, CHN
Nanjing Gaoke Co Ltd is a China-based company engaged in real estate and municipal businesses, medical health business, and equity investment business. Its real estate business includes residential development, commercial operations, and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals.
58GF Score

Get the complete analysis for SHSE:600064

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.45
Price
¥7.83
GF Value